Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 082
mi
from
Wichita Falls, TX
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 082
mi
from
Wichita Falls, TX
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 111
mi
from
Murray, UT
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 111
mi
from
Murray, UT
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 064
mi
from
Charlottesville, VA
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 064
mi
from
Charlottesville, VA
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 014
mi
from
Bothell, WA
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 014
mi
from
Bothell, WA
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #027
mi
from
Seattle, WA
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #027
mi
from
Seattle, WA
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 007
mi
from
Middleton, WI
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 007
mi
from
Middleton, WI
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 049
mi
from
Milwaukee, WI
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 049
mi
from
Milwaukee, WI
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 057
mi
from
Waukesha, WI
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 057
mi
from
Waukesha, WI
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #021
mi
from
Garden Grove, CA
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #021
mi
from
Garden Grove, CA
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 008
mi
from
Redlands, CA
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 008
mi
from
Redlands, CA
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 1854
mi
from
Hialeah, FL
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 1854
mi
from
Hialeah, FL
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #005
mi
from
North Miami, FL
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #005
mi
from
North Miami, FL
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 004
mi
from
Overland Park, KA
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 004
mi
from
Overland Park, KA
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 066
mi
from
Mason, OH
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 066
mi
from
Mason, OH
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 064
mi
from
Middleburg Heights, OH
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 064
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 014
mi
from
Austin, TX
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 014
mi
from
Austin, TX
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
mi
from
Bellevue, WA
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 033
mi
from
San Juan,
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 033
mi
from
San Juan,
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site #015
mi
from
Fort Myers, FL
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site #015
mi
from
Fort Myers, FL
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 066
mi
from
Smyrna, GA
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 066
mi
from
Smyrna, GA
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 086
mi
from
Saint Charles, MO
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 086
mi
from
Saint Charles, MO
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site
mi
from
Albuquerque, NM
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 020
mi
from
Bismarck, ND
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 020
mi
from
Bismarck, ND
Click here to add this to my saved trials
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/8/2018
Forest Investigative Site 045
mi
from
The Woodlands, TX
To Evaluate the Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
A Phase 3, Long-Term, Open-Label Study of Safety and Tolerability of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/8/2018
Forest Investigative Site 045
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Brain Imaging of rTMS Treatment for Depression
A Causal Neural Network-level Understanding of Depression and Its Treatment Through Concurrent TMS and fMRI
Status: Enrolling
Updated:  3/10/2018
Stanford University
mi
from
Palo Alto, CA
Brain Imaging of rTMS Treatment for Depression
A Causal Neural Network-level Understanding of Depression and Its Treatment Through Concurrent TMS and fMRI
Status: Enrolling
Updated: 3/10/2018
Stanford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Beat the Blues in Pregnancy Study - Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation (TMS) in Pregnant Women With Depressive Disorder
Status: Enrolling
Updated:  3/14/2018
Penn Center for Women's Behavioral Wellness
mi
from
Philadelphia, PA
Beat the Blues in Pregnancy Study - Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation (TMS) in Pregnant Women With Depressive Disorder
Status: Enrolling
Updated: 3/14/2018
Penn Center for Women's Behavioral Wellness
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Birmingham, AL
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Little Rock, AR
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Beverly Hills, CA
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Cerritos, CA
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Cerritos, CA
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Denver, CO
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Hamden, CT
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Hamden, CT
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
North Miami, FL
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Orlando, FL
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Atlanta, GA
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Smyrna, GA
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Overland Park, KA
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Baltimore, MD
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Willingboro, NJ
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Willingboro, NJ
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Albuquerque, NM
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Portland, OR
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Memphis, TN
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
San Antonio, TX
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
Clinical Research Facility
mi
from
Bellevue, WA
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated:  3/16/2018
mi
from
Buenos Aires,
A Study in Adult Patients With Major Depressive Disorder
A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment With LY2216684 in Adult Patients With Major Depressive Disorder
Status: Enrolling
Updated: 3/16/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
Microbiome of Depression & Treatment Response to Citalopram
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Status: Enrolling
Updated:  3/20/2018
Mayo Clinic Florida
mi
from
Jacksonville, FL
Microbiome of Depression & Treatment Response to Citalopram
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Status: Enrolling
Updated: 3/20/2018
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Microbiome of Depression & Treatment Response to Citalopram
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Status: Enrolling
Updated:  3/20/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Microbiome of Depression & Treatment Response to Citalopram
Microbiome of Depression &Amp; Treatment Response to Citalopram: A Feasibility Study
Status: Enrolling
Updated: 3/20/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
A Double-Blind Placebo-Controlled Study of Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults With Bipolar Disorder, Major Depressive Disorder, Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  3/21/2018
University of Cincinnati
mi
from
Cincinnati, OH
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
A Double-Blind Placebo-Controlled Study of Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults With Bipolar Disorder, Major Depressive Disorder, Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 3/21/2018
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Brain Mechanisms of Human Motivation
Multi Level Analysis of Positive Valence Systems Across Mood Disorders
Status: Enrolling
Updated:  3/22/2018
McLean Hospital
mi
from
Belmont, MA
Brain Mechanisms of Human Motivation
Multi Level Analysis of Positive Valence Systems Across Mood Disorders
Status: Enrolling
Updated: 3/22/2018
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials